Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Melanotan-2 Sexual Health Research Evidence: Full Comparison

Men with psychogenic ED MC4R activation in hypothalamus + dopamine modulation 80% vs 10% placebo 37 min onset / 8 hr duration Nausea (30%), flushing (25%), no serious AEs Strongest evidence for CNS-mediated ED; outperformed placebo consistently across trials M

This comparison does not assign a generated winner or score.

  • Men with psychogenic ED
  • MC4R activation in hypothalamus + dopamine modulation
  • 80% vs 10% placebo
  • 37 min onset / 8 hr duration
  • Nausea (30%), flushing (25%), no serious AEs
  • Strongest evidence for CNS-mediated ED; outperformed placebo consistently across trials
  • Men with organic ED (vascular/diabetic)
  • MC4R + peripheral smooth muscle relaxation
  • 60% vs 15% placebo
  • 45 min onset / 6–8 hr duration
  • Nausea (35%), GI discomfort (20%)
  • Moderate efficacy; less effective than psychogenic cases but still clinically meaningful
  • Women with HSDD
  • Hypothalamic MC4R + dopamine reward pathways
  • Significant desire increase vs placebo
  • 60–90 min onset / 8–10 hr duration
  • Nausea (40%), flushing (30%)
  • Promising preliminary data; mechanism distinct from hormonal treatments
  • Combination with PDE5 inhibitors
  • Dual pathway (CNS arousal + NO-mediated vasodilation)
  • No controlled trials
  • Theoretical synergy untested
  • Unknown interaction profile
  • No published evidence; theoretically complementary but unstudied
More references

Related material